EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease

Shu-Tong Huang iD, Jin-Chong Luo, Guo-Hui Zhong iD, Li-Ping Teng, Cai-Yan Yang, Chun-Li Tang iD, Lin Jing iD, Zhong-Bo Zhou iD, Jing Liu, Neng Jiang iD

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s432170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Shu-Tong Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeurodegenerative DiseasesMiceAnimalsTacrineCholinesterasesSelegilineMonoamine OxidaseCholinesterase InhibitorsMonoamine Oxidase InhibitorsAcetylcholinesteraseDrug DesignStructure-Activity RelationshipAmyloid beta-PeptidesTaurine

Stichwörter der Autor:innen

Alzheimer’s diseasecholinesterasedesignedmonoamine oxidasemulti-target

Substanzen

TacrineCholinesterasesSelegilineMonoamine OxidaseCholinesterase Inhibitors2-(N-cyclohexylamino)ethanesulfonic acidMonoamine Oxidase InhibitorsAcetylcholinesteraseAmyloid beta-PeptidesTaurine

Autor:innen und Institutionen

  • Department of Pharmacy, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.
  • Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
  • School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, People's Republic of China.
  • School of Pharmacy, Youjiang Medical University for Nationalities, Baise, Guangxi, People's Republic of China.

ORCID-Profile: Shu-Tong Huang, Guo-Hui Zhong, Chun-Li Tang, Lin Jing, Zhong-Bo Zhou, Neng Jiang

Zitieren

APA

Huang, S. T., Luo, J. C., Zhong, G. H., Teng, L. P., Yang, C. Y., Tang, C. L., Jing, L., Zhou, Z. B., Liu, J., & Jiang, N. (2024). In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s432170

Vancouver

Huang ST, Luo JC, Zhong GH, Teng LP, Yang CY, Tang CL, et al. In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s432170

BibTeX
@article{Huang2024,
  author = {Huang, Shu-Tong and Luo, Jin-Chong and Zhong, Guo-Hui and Teng, Li-Ping and Yang, Cai-Yan and Tang, Chun-Li and Jing, Lin and Zhou, Zhong-Bo and Liu, Jing and Jiang, Neng},
  title = {In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s432170}
}
Kostenlos starten →